Lifeward Ltd. (LFWD) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and welcome to the LifeWord, Inc. fourth quarter 2025 earnings conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad, and to withdraw your question, please press star then two. Please note today's event is being recorded. I would now like to turn the conference over to Alma Ghadar, Chief Financial Officer. Please go ahead. Thank you, Rocco, and thanks everyone who's joining us on the call today. My name is Alma Ghadar. I'm LifeWord Chief Financial Officer, and with me on today's call is our President and Chief Executive Officer, Mark Grant. Earlier this morning, LifeWord issued a press release detailing the financial results for the fourth quarter and the full year ended December 31st, 2025. I would ask you to review the full text of our forward-looking statements from the press release. We anticipate making projections during this call, and actual results could differ materially due to several factors, including those outlined in our latest filing with the SEC. And with that, I will turn the call over to Mark. Good morning, and thanks, everyone, for joining us on the call today. Before we get into the details of the quarter and the year, I want to start with what we believe is fundamental to the LifeWord investment thesis today. We're executing against a strategy to build a leading, diversified biomedical innovation company with multiple technology platforms and strong clinical foundations. Importantly, we're establishing a clear line of sight to scale through continued progress in reimbursement, ...